Ingrid Gafanhão

Ingrid joined Redwheel in September 2023 as a Healthcare Analyst in the Global Sustainable Healthcare Investment team. Prior to Redwheel, Ingrid was a Healthcare Equity Research Analyst at Bryan Garnier and Kempen, covering the key European Biotechs leading innovation in the therapeutic space. Ingrid is part of the Business Development & Finance Committee for the International Society for Cell & Gene Therapy, which strives to bridge the knowledge gap between investigators and investors in the sector.
Ingrid holds a Master’s degree in Science-Based Business from Leiden University and a Bachelor’s degree in Biology from Universidade Estadual de Campinas.

Play Video
Play Video
Play Video
Play Video
Play Video
Play Video
Play Video